Monitoring personnel | 1. Sedation monitoring requires a multidisciplinary team approach, including physicians, pharmacists, respiratory therapists, neurosurgical intensive care nurses, and charge nurses, all of whom need to receive professional education and training22,23,26 | 1 | A |
| 2. Monitoring goal-setters: physicians, pharmacists, respiratory therapists23 | 1 | A |
| 3. Sedation depth assessment and program implementation: physicians, neurosurgical critical care nurses, and charge nurses21,23 | 1 | A |
Monitoring targets | 4. It is recommended that the depth of sedation be individualized according to the functional status of the organs, that goal-oriented sedation strategies be implemented to avoid over-sedation, and that sedation be gradually reduced to the lowest achievable effective sedative dose12,22,24 | 1 | B |
| 5. Indications for shallow sedation: patients with relatively stable organ function and recovery period, such as patients with mild to moderate craniocerebral injury24,27 | 2 | A |
| 6. Indications for deep sedation: patients with unstable organ function and acute stage of stress: (1) patients with severe human-machine incoordination of mechanical ventilation; (2) severe acute respiratory distress syndrome (ARDS), early and short course of neuromuscular blocking agents, prone ventilation, and pulmonary reanimation as a basis of treatment; (3) patients with severe craniocerebral injury with cranial hypertension; (4) epilepsy in a state of persistence; (5) patients who need to be tightly braked by surgery (6) Anyone who needs to be treated with neuromuscular blocking agents24,27 | 5 | A |
| 7. Suggested target values for sedation depth are: light sedation, Richmond Agitation Sedation Scale (RASS) −2 ∼ +1 points, Rike Sedation Agitation Scale (SAS) 3∼4 points; deep sedation, RASS −3 ∼ −4 points, SAS 2 points; combined with the application of neuromuscular blockers, RASS -5 points, SAS 1 point. The ideal state of sedation is: RASS −1 ∼ 0 points1,12,23,24,26,27 | 5 | A |
Monitoring tools | 8. Subjective sedation assessment tools: Richmond Agitation Sedation Scale (RASS), Ramsay Sedation Scale (RSS), Rike Sedation Agitation Scale (SAS), Minnesota Sedation Assessment Tool (MSAT), and Bizek Agitation Scale1,22–24,26 | 3 | B |
| 9. Objective assessment methods: Bispectral Index Score (BIS), Narcotrend Index (NI), Cerebral State Index (CSI), Auditory Evoked Potentials (AEP), Muscle Activity Score (MAAS), and Entropy Index (SE)10,12,24,26 | 3 | B |
| 10. Multimodal monitoring techniques can dynamically assess the safety and efficacy of analgesia and sedation from different perspectives12,27 | 5 | B |
| 11. Objective brain function monitoring is recommended for assessing the level of sedation in patients under deep sedation or combined with neuromuscular blocking agents10,24 | 3 | A |
Timing and content of monitoring | 12. After sedation is administered, the depth of sedation should be assessed and recorded hourly at the bedside, and medication should be adjusted until the sedation goal is achieved12,22–25 | 3 | A |
| 13. Patients’ organ functional status and organ reserve capacity should be routinely assessed before and after sedation24 | 1 | A |
| 14. Monitor vital signs: pulse, blood pressure, heart rate, temperature, respiration, oxygen saturation, end-expiratory carbon dioxide21,27 | 5 | A |
| 15. Attend to conditions relevant to the neurosurgical specialty: assessment of consciousness, pupillary changes, intracranial pressure monitoring, neurological physical examination, laboratory tests, and imaging studies27 | 5 | A |
| 16. Monitor the patient’s response to medications and maneuvers: the patient’s level of alertness, depth of respiration, and response to painful stimuli21 | 5 | B |
| 17. Perform DSI and NWT on deeply sedated patients every morning in the absence of contraindications12,22,24,25 | 5 | A |
| 18. DSI monitoring consists of: compliant eye opening, eye tracking, compliant fist clenching, and compliant toe moving, with at least 3 of these items being met before sedation is reintroduced24 | 1 | A |
| 19. Contraindications to NWT: patients with neurocritical conditions such as refractory status epilepticus, paroxysmal sympathetic activity, refractory intracranial hypertension, implantation of oxygen monitoring devices in brain tissue, hemodynamic instability, patients undergoing targeted temperature management, and end-of-life care during high-intensity therapy12,23,24,26 | 1 | A |
| 20. Patients with refractory intracranial hypertension undergoing intracranial pressure monitoring, DSI or NWT should be attempted only at the beginning of treatment and when intracranial pressure is close to normal26 | 5 | A |